Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| 4D Molecular Therapeutics, Inc. | 217,000 | reported | 25 Mar 2026 | tx 116+622,247−133,023 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 25 Mar 2026 | GRANT_AWARD | 4D Molecular Therapeutics, Inc. | 217,000 | 0.00 USD | deriv |
| 16 Dec 2025 | EXERCISE | 4D Molecular Therapeutics, Inc. | 1,635 | 4.14 USD | |
| 16 Dec 2025 | SALE | 4D Molecular Therapeutics, Inc. | 1,635 | 10.90 USD | |
| 16 Dec 2025 | EXERCISE | 4D Molecular Therapeutics, Inc. | 1,635 | 0.00 USD | deriv |
| 17 Nov 2025 | EXERCISE | 4D Molecular Therapeutics, Inc. | 1,635 | 4.14 USD | |
| 17 Nov 2025 | SALE | 4D Molecular Therapeutics, Inc. | 1,635 | 10.59 USD | |
| 17 Nov 2025 | EXERCISE | 4D Molecular Therapeutics, Inc. | 1,635 | 0.00 USD | deriv |
| 24 Oct 2025 | SALE | 4D Molecular Therapeutics, Inc. | 2,678 | 12.00 USD | |
| 24 Oct 2025 | EXERCISE | 4D Molecular Therapeutics, Inc. | 1,084 | 6.49 USD | |
| 24 Oct 2025 | EXERCISE | 4D Molecular Therapeutics, Inc. | 1,084 | 0.00 USD | deriv |
| 16 Oct 2025 | EXERCISE | 4D Molecular Therapeutics, Inc. | 1,635 | 4.14 USD | |
| 16 Oct 2025 | SALE | 4D Molecular Therapeutics, Inc. | 1,635 | 10.17 USD | |
| 16 Oct 2025 | EXERCISE | 4D Molecular Therapeutics, Inc. | 1,635 | 0.00 USD | deriv |
| 09 Oct 2025 | SALE | 4D Molecular Therapeutics, Inc. | 2,408 | 10.00 USD | |
| 23 Sept 2025 | SALE | 4D Molecular Therapeutics, Inc. | 2,407 | 8.00 USD | |
| 06 Mar 2025 | GRANT_AWARD | 4D Molecular Therapeutics, Inc. | 78,500 | 0.00 USD | deriv |
| 16 Sept 2024 | SALE | 4D Molecular Therapeutics, Inc. | 500 | 16.33 USD | |
| 16 Sept 2024 | EXERCISE | 4D Molecular Therapeutics, Inc. | 500 | 6.49 USD | |
| 16 Sept 2024 | EXERCISE | 4D Molecular Therapeutics, Inc. | 500 | 0.00 USD | deriv |
| 19 Aug 2024 | EXERCISE | 4D Molecular Therapeutics, Inc. | 500 | 6.49 USD | |
| 19 Aug 2024 | SALE | 4D Molecular Therapeutics, Inc. | 500 | 15.00 USD | |
| 19 Aug 2024 | EXERCISE | 4D Molecular Therapeutics, Inc. | 500 | 0.00 USD | deriv |
| 16 Jul 2024 | SALE | 4D Molecular Therapeutics, Inc. | 1,750 | 27.11 USD | |
| 16 Jul 2024 | EXERCISE | 4D Molecular Therapeutics, Inc. | 1,250 | 8.04 USD | |
| 16 Jul 2024 | EXERCISE | 4D Molecular Therapeutics, Inc. | 500 | 6.49 USD |